CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

NCT02742727 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
T-cell Prolymphocytic Leukemia
T-cell Large Granular Lymphocytic Leukemia
Peripheral T-cell Lymphoma, NOS
Angioimmunoblastic T-cell Lymphoma
Extranodal NK/T-cell Lymphoma, Nasal Type
Enteropathy-type Intestinal T-cell Lymphoma
Hepatosplenic T-cell Lymphoma

Interventions

BIOLOGICAL: anti-CD7 CAR-pNK cells

Sponsor

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Collaborators

[object Object]
[object Object]